Table 1.
Patient Demographics and Clinical Details for all patients, patients with Sexual Well-being Scores, and patients without Sexual Well-being Scores.
| Patient Demographics | All Patients (n=2,941) | Available (n=1,566) | Missing (n=1,375) | p-value |
|---|---|---|---|---|
| Age at Surgery 1 | 49 (42, 56) | 49 (42, 55) | 49 (42,57) | 0.3 |
|
Race White Asian Black Other |
2,116 (72%) 287 (9.8%) 293 (10%) 245 (8.3%) |
1,162 (74%) 135 (8.6%) 142 (9.1%) 127 (8.1%) |
954 (69%) 152 (11%) 151 (11%) 118 (9.6%) |
0.021 |
|
Ethnicity Not Hispanic Hispanic Unknown |
2,451 (83%) 299 (10%) 191 (6.5%) |
1,326 (85%) 140 (8.9%) 100 (6.4%) |
1,125 (82%) 159 (12%) 91 (6.6%) |
0.057 |
|
Marital Status Married Separated Single |
2,046 (70%) 292 (9.95%) 603 (21%) |
1,124 (72%) 128 (8.2%) 314 (20%) |
922 (67%) 164 (12%) 289 (21%) |
0.001 |
|
Language English Non-English |
2,840 (97%) 101 (3.4%) |
1,533 (98%) 33 (2.1%) |
1,307 (95%) 68 (4.9%) |
<0.001 |
| Income 1 | $103,548 ($77,044, $131,412) | $106,631 ($79,524, $131,412) | $101,405 ($73,856, $131,013) | 0.024 |
|
Insurance
Commercial Medicaid Medicare Self-Pay |
2,345 (80%) 184 (6.3%) 385 (13%) 27 (0.9%) |
1,290 (82%) 75 (4.8%) 190 (12%) 11 (0.7%) |
1,055 (77%) 109 (7.9%) 195 (14%) 16 (1.2%) |
<0.001 |
| Body Mass Index (BMI) 1 | 24.2 (21.5, 27.8) | 24.3 (21.6, 28.1) | 24.2 (21.3 27.7) | 0.3 |
|
Smoking Status Never Smoker Current Smoker Former Smoker |
2,233 (76%) 75 (2.6%) 633 (22%) |
1,186 (76%) 33 (2.1%) 347 (22%) |
1,047 (76%) 42 (3.1%) 286 (21%) |
0.2 |
|
Menopause Status Premenopausal Postmenopausal Unknown |
322 (11%) 1,191 (40%) 1,428 (49%) |
136 (8.7%) 615 (39%) 815 (52%) |
186 (14%) 576 (42%) 613 (45%) |
<0.001 |
|
Comorbidities Diabetes Cardiovascular Disease Hypertension Psychiatric Diagnoses Lymphedema |
164 (5.6%) 704 (24%) 665 (23%) 1,651 (56%) 246 (8.4%) |
81 (5.2%) 390 (25%) 332 (21%) 890 (57%) 141 (9.0%) |
83 (6.0%) 314 (23%) 333 (24%) 761 (55%) 105 (7.6%) |
0.3 0.2 0.051 0.4 0.2 |
| Clinical Characteristics | ||||
|
Lymph Node Axillary lymph node dissection Sentinel lymph node biopsy |
581 (20%) 2,263 (77%) |
297 (19%) 1,219 (78%) |
284 (21%) 1,044 (76%) |
0.3 0.2 |
|
Chemotherapy None Neoadjuvant Adjuvant |
654 (22%) 1,185 (40%) 1,102 (37%) |
363 (23%) 614 (39%) 589 (38%) |
291 (21%) 571 (42%) 513 (37%) |
0.3 |
|
Radiation None Neoadjuvant Adjuvant |
2,135 (73%) 310 (11%) 496 (17%) |
1,153 (74%) 181 (12%) 232 (15%) |
982 (71%) 129 (9.4%) 264 (19%) |
0.003 |
| Aromatase inhibitor | 1,045 (63%) | 532 (34%) | 513 (37%) | 0.059 |
|
Mastectomy Type Skin sparing Nipple sparing |
2,586 (88%) 355 (12%) |
1,379 (88%) 187 (12%) |
1,207 (88%) 168 (12%) |
0.8 |
|
Timing of Reconstruction Immediate Delayed |
2,406 (82%) 535 (18%) |
1,256 (80%) 310 (20%) |
1,150 (84%) 225 (16%) |
0.016 |
|
Laterality Bilateral Unilateral |
1,724 (59%) 1,217 (41%) |
964 (62%) 602 (38%) |
760 (55%) 615 (45%) |
<0.001 |
|
Reconstruction Method Implant Autologous |
2,023 (69%) 918 (31%) |
974 (62%) 592 (38%) |
1,049 (76%) 326 (24%) |
<0.001 |
| Complications | ||||
| Readmission within 90 days | 250 (8.5%) | 133 (8.5%) | 117 (8.5%) | >0.9 |
| Reoperation within 90 days | 522 (18%) | 289 (18%) | 233 (17%) | 0.3 |
1
Median (Interquartile Range)